AIDS News and Research

RSS

PlusNews reviews AVAC priorities for 2013 HIV prevention agenda

"If the world scales-up HIV treatment and prevention in the next two years, a critical tipping point -- in which those on treatment outnumber those newly infected with the virus -- could be reached, according to the global HIV prevention advocacy organization AVAC," PlusNews reports.

15 Dec 2012

Though progress made, global burden of HIV/AIDS requires greater, 'better' response

"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.

15 Dec 2012

Examining developing country contributions to AIDS response

"World AIDS Day 2012 offered numerous personal stories in the global fight against HIV and AIDS, but perhaps the most intriguing story, however, was a policy one: How developing countries are making significant contributions to the fight against AIDS in their own countries,"

15 Dec 2012

WHO releases new guidelines for interventions aimed at protecting sex workers from HIV

The WHO on Wednesday "released new guidelines providing technical recommendations on effective interventions for the prevention and treatment of HIV and other sexually transmitted infections (STIs) among sex workers and their clients," New Europe Online reports.

15 Dec 2012

Study suggests that existing HIV drug could be a potential therapy for Staph infections

A new study by NYU School of Medicine researchers suggests that an existing HIV drug called maraviroc could be a potential therapy for Staphylococcus aureus, a notorious and deadly pathogen linked to hundreds of thousands of hospitalizations each year.

15 Dec 2012

IRIN examines HIV/AIDS response in Guinea-Bissau

IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, "One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut."

14 Dec 2012

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Friday published Issue 206 of its "Global Fund Observer."

14 Dec 2012

Gender inequality must be addressed to 'get to zero' in AIDS epidemic

"What does it take to get to zero? While reflecting on the theme of this past World AIDS Day (Getting to zero, Zero new infections, Zero discrimination, Zero deaths), I asked myself this question," Lisa MacDonald, project manager at HealthBridge Foundation of Canada, writes in a Huffington Post Canada opinion piece.

14 Dec 2012

Lutheran Malaria Initiative holds advocacy day on Capitol Hill

In the U.N. Foundation Blog, Gretchen King, director of the Lutheran Malaria Initiative (LMI), examines the efforts of LMI to "mobiliz[e] U.S. Lutherans in the global effort to end malaria deaths in Africa."

13 Dec 2012

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

"Global efforts to reach the 'three zeros' for women and girls -- zero new HIV infections, zero discrimination and zero AIDS-related deaths -- are gaining momentum," Michelle Bachelet, executive director of U.N. Women, Michel Sidibe, executive director of UNAIDS, and Jennifer Gatsi Mallet, executive director of the Namibia Women's Health Network, write in an Inter Press Service opinion piece.

13 Dec 2012

Ceramic cookstoves may not reduce risk of pneumonia in young rural Kenyan children

Inexpensive, locally-produced ceramic cookstoves may produce less smoke than traditional indoor 3-stone firepits, but they don't significantly reduce indoor air pollution or the risk of pneumonia in young children, according to results from a small, year-long observational study by researchers working in rural Kenya.

13 Dec 2012

AstraZeneca, Case Western Reserve initiate AZD5847 Phase 2a trial in TB

Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV co-infection.

12 Dec 2012

Drugs for Neglected Diseases receives UNITAID grant for paediatric HIV programme

The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its paediatric HIV programme.

12 Dec 2012

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Friday published Issue 205 of its "Global Fund Observer."

11 Dec 2012

GlobalPost series examines HIV/AIDS in European, MENA regions

As part of its ongoing series, titled "The State of AIDS," GlobalPost published two articles examining the epidemic in different regions. In Eastern Europe, rates of HIV/AIDS diagnoses have risen in several countries, including Ukraine and Russia, according to the first article, which discusses some of the potential reasons for the increases.

11 Dec 2012

PEPFAR blueprint relies on science to inform policies, SciDev.Net reports

"Science is at the center of efforts to design and implement more effective preventative and care programs for HIV/AIDS set out in a blueprint published by a U.S. government initiative that fights the disease," SciDev.Net reports, referencing the PEPFAR Blueprint: Creating an AIDS-free Generation that was released November 29.

11 Dec 2012

Governments, donors should follow PMI model of testing drugs for quality

"[W]e are losing the global fight against bad medicines," and though "[s]ome progress is being made," the "problem is that ... crackdowns tend to focus on counterfeit drugs" while a "much bigger public health problem ... is substandard drugs that are the result of shoddy manufacturing and handling -- or perhaps worse, deliberate corner-cutting," Roger Bate, a resident scholar at the American Enterprise Institute, writes in an opinion piece in The Hill's "Congress Blog."

11 Dec 2012

Boston College professor to research into new drugs that can prevent onset of toxoplasmosis

The American Cancer Society has awarded a four-year, $720,000 grant to Boston College Associate Professor of Biology Marc-Jan Gubbels for research into potential new drugs that can prevent the onset of toxoplasmosis in cancer patients with weakened immune systems.

10 Dec 2012

IQWiG investigates benefits of rilpivirine for HIV treatment

Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).

8 Dec 2012

New public-private partnership will allow Brazil to produce patented ARV for national treatment program

For the first time, Brazil in 2013 will enter into a new type of public-private partnership that allows the nation to produce a generic version of the antiretroviral (ARV) drug atazanavir sulphate, which will be under patent through its producer Bristol-Myers Squibb until 2017, Inter Press Service reports.

8 Dec 2012

AIDS News and Research

PlusNews reviews AVAC priorities for 2013 HIV prevention agenda

Though progress made, global burden of HIV/AIDS requires greater, 'better' response

Examining developing country contributions to AIDS response

WHO releases new guidelines for interventions aimed at protecting sex workers from HIV

Study suggests that existing HIV drug could be a potential therapy for Staph infections

IRIN examines HIV/AIDS response in Guinea-Bissau

Aidspan publishes new issue of 'Global Fund Observer'

Gender inequality must be addressed to 'get to zero' in AIDS epidemic

Lutheran Malaria Initiative holds advocacy day on Capitol Hill

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

Ceramic cookstoves may not reduce risk of pneumonia in young rural Kenyan children

AstraZeneca, Case Western Reserve initiate AZD5847 Phase 2a trial in TB

Drugs for Neglected Diseases receives UNITAID grant for paediatric HIV programme

Aidspan publishes new issue of 'Global Fund Observer'

GlobalPost series examines HIV/AIDS in European, MENA regions

PEPFAR blueprint relies on science to inform policies, SciDev.Net reports

Governments, donors should follow PMI model of testing drugs for quality

Boston College professor to research into new drugs that can prevent onset of toxoplasmosis

IQWiG investigates benefits of rilpivirine for HIV treatment

New public-private partnership will allow Brazil to produce patented ARV for national treatment program

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News